FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 49 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |